Key result
Multiomics technologies, including genomics, transcriptomics, epigenomics, proteomics, and metabolomics, offer new insights into the molecular pathogenesis of cardiovascular diseases.
Integrating multiomics and genetic profiling into clinical practice may enable individualized medicine and novel therapeutic targets for ischemic heart disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Szabó et al. (2019) conducted a review in Coronary artery disease. Multiomics approach was evaluated. Multiomics technologies, including genomics, transcriptomics, epigenomics, proteomics, and metabolomics, offer new insights into the molecular pathogenesis of cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: